 | • レポートコード：QFJ1-5356 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、合成致死性基準薬剤＆標的の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・合成致死性基準薬剤＆標的の市場動向 ・企業の競争状況、市場シェア ・合成致死性基準薬剤＆標的の種類別市場規模と予測2016-2027（単剤療法、併用療法） ・合成致死性基準薬剤＆標的の用途別市場規模と予測2016-2027（医療研究機関、病院・クリニック、その他） ・合成致死性基準薬剤＆標的の北米市場規模2016-2027（アメリカ、カナダ） ・合成致死性基準薬剤＆標的の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・合成致死性基準薬剤＆標的のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・合成致死性基準薬剤＆標的の中南米市場規模2016-2027（メキシコ、ブラジル） ・合成致死性基準薬剤＆標的の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、AstraZeneca、BeiGene、Clovis Oncology、GlaxoSmithKline、Pfizer、AtlasMedx、Chordia Therapeutics、IDEAYA Biosciences、Mission Therapeutics、Repare Therapeutics、Sierra Oncology、SyntheX Labs） ・結論 |
In cancers, where mutations have led to the loss of function of one gene, using a drug molecule that specifically targets the corresponding gene of the synlet pair has been demonstrated to be a viable and effective therapeutic regimen. Recent advances in biomarker research, including the development of companion diagnostics, in combination with modern molecular screening platforms, which include clustered regularly interspaced short palindromic repeats (CRISPR)- and RNA interference (RNAi)-based screening techniques, have led to the identification of a number of synthetically lethal gene pairs.
Market Analysis and Insights: Global Synthetic Lethality-based Drugs and Targets Market
The global Synthetic Lethality-based Drugs and Targets market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Synthetic Lethality-based Drugs and Targets market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Synthetic Lethality-based Drugs and Targets market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Synthetic Lethality-based Drugs and Targets market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Synthetic Lethality-based Drugs and Targets market.
Global Synthetic Lethality-based Drugs and Targets Scope and Market Size
Synthetic Lethality-based Drugs and Targets market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Synthetic Lethality-based Drugs and Targets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Medical Research Institution
Hospital and Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
AstraZeneca
BeiGene
Clovis Oncology
GlaxoSmithKline
Pfizer
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2016-2027)
2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions
2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Share by Regions (2016-2021)
2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027)
2.3 Synthetic Lethality-based Drugs and Targets Industry Dynamic
2.3.1 Synthetic Lethality-based Drugs and Targets Market Trends
2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue
3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2016-2021)
3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2016-2021)
3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2020
3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2016-2021)
4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2016-2021)
5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application
6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application
7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type
8.2.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application
8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
8.4.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type
9.2.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
9.2.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
9.2.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application
9.3.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
9.3.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
9.3.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country
9.4.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
9.4.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type
10.2.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application
10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
10.4.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 BeiGene
11.3.1 BeiGene Company Details
11.3.2 BeiGene Business Overview
11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.3.5 BeiGene Recent Development
11.4 Clovis Oncology
11.4.1 Clovis Oncology Company Details
11.4.2 Clovis Oncology Business Overview
11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.4.5 Clovis Oncology Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 AtlasMedx
11.7.1 AtlasMedx Company Details
11.7.2 AtlasMedx Business Overview
11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.7.5 AtlasMedx Recent Development
11.8 Chordia Therapeutics
11.8.1 Chordia Therapeutics Company Details
11.8.2 Chordia Therapeutics Business Overview
11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.8.5 Chordia Therapeutics Recent Development
11.9 IDEAYA Biosciences
11.9.1 IDEAYA Biosciences Company Details
11.9.2 IDEAYA Biosciences Business Overview
11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.9.5 IDEAYA Biosciences Recent Development
11.10 Mission Therapeutics
11.10.1 Mission Therapeutics Company Details
11.10.2 Mission Therapeutics Business Overview
11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.10.5 Mission Therapeutics Recent Development
11.11 Repare Therapeutics
11.11.1 Repare Therapeutics Company Details
11.11.2 Repare Therapeutics Business Overview
11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.11.5 Repare Therapeutics Recent Development
11.12 Sierra Oncology
11.12.1 Sierra Oncology Company Details
11.12.2 Sierra Oncology Business Overview
11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.12.5 Sierra Oncology Recent Development
11.13 SyntheX Labs
11.13.1 SyntheX Labs Company Details
11.13.2 SyntheX Labs Business Overview
11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.13.5 SyntheX Labs Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2016-2021)
Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2016-2021)
Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020)
Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2016-2021)
Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Synthetic Lethality-based Drugs and Targets Product
Table 64. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. AstraZeneca Company Details
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
Table 69. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. BeiGene Company Details
Table 72. BeiGene Business Overview
Table 73. BeiGene Synthetic Lethality-based Drugs and Targets Product
Table 74. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 75. BeiGene Recent Development
Table 76. Clovis Oncology Company Details
Table 77. Clovis Oncology Business Overview
Table 78. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
Table 79. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 80. Clovis Oncology Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
Table 84. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Synthetic Lethality-based Drugs and Targets Product
Table 89. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. AtlasMedx Company Details
Table 92. AtlasMedx Business Overview
Table 93. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
Table 94. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 95. AtlasMedx Recent Development
Table 96. Chordia Therapeutics Company Details
Table 97. Chordia Therapeutics Business Overview
Table 98. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 99. Chordia Therapeutics Recent Development
Table 100. IDEAYA Biosciences Company Details
Table 101. IDEAYA Biosciences Business Overview
Table 102. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
Table 103. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 104. IDEAYA Biosciences Recent Development
Table 105. Mission Therapeutics Company Details
Table 106. Mission Therapeutics Business Overview
Table 107. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 108. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 109. Mission Therapeutics Recent Development
Table 110. Repare Therapeutics Company Details
Table 111. Repare Therapeutics Business Overview
Table 112. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 113. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 114. Repare Therapeutics Recent Development
Table 115. Sierra Oncology Company Details
Table 116. Sierra Oncology Business Overview
Table 117. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
Table 118. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 119. Sierra Oncology Recent Development
Table 120. SyntheX Labs Company Details
Table 121. SyntheX Labs Business Overview
Table 122. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
Table 123. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 124. SyntheX Labs Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2027
Figure 5. Medical Research Institution Case Studies
Figure 6. Hospital and Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered
Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions: 2020 VS 2027
Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2020
Figure 14. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2020
Figure 16. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
Figure 17. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027)
Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 20. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 21. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 22. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 26. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 27. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 28. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2016-2027)
Figure 38. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 46. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 47. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 54. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 59. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 60. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 63. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 64. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 65. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 66. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 67. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 68. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 69. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
ITOスパッタリングターゲットのグローバル市場2021 Indium tin oxide sputtering targets (ITO sputter target) allow deposition of high value transparent conductive films. The global ITO sputtering target consumer market is mainly in Korea, China, Japan and Taiwan in Asia. In 2018, it accounted for more than 90% of the global market share. It expected …- ターゲット用高純度銅のグローバル市場2021 High purity copper for Targets is a kind of copper whose purity is above 5 N (Cu 99.999% or higher, N represents the purity of copper, N in front of the greater the number the higher the purity of copper).High purity copper as a new material, in addition to high-tech areas like preparating standard …
- 世界の眼瞼炎薬市場規模・現状・予測（2021年-2027年） Blepharitis is one of the most common ocular conditions characterized by inflammation, scaling, reddening, and crusting of the eyelid. This condition may also cause burning, itching, or a grainy sensation when introducing foreign objects or substances to the eye. The development of novel drug formul…
- 世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…
- 世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Drugs Market The global Gene Therapy Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes…